NPPB and hydrops fetalis: For instance, in PARADIGM-HF [49], a randomised controlled trial comparing a novel drug (LCZ696) against the established ACE-inhibitor Enalapril, levels of BNP / NT-proBNP in patients’ blood plasma were used as a criterion for including patients into the study population.